Ionis Pharmaceuticals, Inc. is a massive, publicly traded biotechnology enterprise headquartered in Carlsbad, California, recognized globally as a pioneer and leader in RNA-targeted drug discovery and antisense technology. The corporation employs a specialized workforce of hundreds of expert research scientists and medical professionals. Generating hundreds of millions in annual revenue and commanding a substantial multi-billion-dollar market capitalization on public stock exchanges, Ionis maintains a robust clinical pipeline of innovative therapeutics targeting severe neurological, cardiovascular, and rare genetic diseases.